Status:

COMPLETED

Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Conditions:

Breast Carcinoma

Eligibility:

All Genders

Brief Summary

This study evaluates Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority (INTENDED for SGM) in identifying the patient, support person and provider barriers to quality care in ...

Detailed Description

PRIMARY OBJECTIVE: I. To determine the important ways the iCanDecide breast cancer decision aid needs revised for SGM people, and how best to integrate a culturally-relevant tool into clinical practi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • SURVIVORS:
  • Self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender
  • Must be a breast cancer survivor, in active treatment or completed active treatment in the last 10 years (not including hormone therapy)
  • Be over age 18
  • English-speaking
  • Received care in the US
  • BREAST ONCOLOGY CLINICIANS: Physicians, advanced practice providers, nurses, psychologists and social workers will be eligible if they:
  • Provide care and/or surgical decision support to individuals diagnosed with early stage breast cancer in the US
  • Are English-speaking

Exclusion

    Key Trial Info

    Start Date :

    August 24 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 15 2023

    Estimated Enrollment :

    28 Patients enrolled

    Trial Details

    Trial ID

    NCT06205394

    Start Date

    August 24 2022

    End Date

    October 15 2023

    Last Update

    January 16 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States, 43210